AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effectiveness of Enhanced External Counterpulsation for Post-acute Stroke Patients

RecruitingNAAges 20 Years - anyAllChina Medical University Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to learn if there benefits combine enhanced external counterpulsation (EECP) with the standard post-acute care (PAC) rehabilitation treatment to treat stroke patients.. The main questions it aims to answer are: What is the feasibility of combining EECP and PAC? Does EECP combined PAC rehabilitation improve functional outcomes of post-stroke patients? Researchers will compare standard PAC rehabilitation and EECP combined PAC rehabilitation to see if EECP has benefits to treat stroke.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with acute cerebrovascular disease, within 1 month after acute attack. * Stable medical condition: (1). Neurological condition: The neurological condition has not deteriorated for more than 72 hours. (2). Vital signs including blood pressure, heartbeat, and body temperature are stable or controllable for more than 72 hours. (3). No complications such as infection, blood abnormalities, gastrointestinal bleeding, or stable or controllable after treatment. * Those whose functional status is moderate to moderately severe functional impairment (MRS 3-4) and who are judged by the medical team to have active rehabilitation potential: (1). Have basic cognition, learning ability and willingness. (2) Have sufficient physical strength: able to maintain a sitting position on a wheelchair or bed edge for at least one hour with support. (3). Be able to actively participate in rehabilitation treatment plans. * Aged over 20 years old Exclusion Criteria: * Patients with atrial fibrillation/arrhythmia. * Within 2 weeks after cardiac catheterization or arterial puncture at the femoral artery puncture site. * Decompensated heart failure (NYHA class 3 or 4). * Left ventricular ejection fraction (EF) \< 30%. * Moderate or severe aortic regurgitation. * Persistent and uncontrolled hypertension (blood pressure persistently \>160/100 mmHg). * Bleeding tendency. * Active phlebitis/venous disease of the lower extremities. * Severe vascular occlusive disease of the lower extremities. * The presence of documented aortic aneurysm/dissection requiring surgical repair. * Pregnancy.
๐Ÿ’Š

What it tests

  • enhanced external counterpulsation
  • post acute care
๐Ÿ“

Where

1 site
China Medical University Hospital Taichung East District Branch
Taichung, Taiwan
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy